Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine 10% Spray for Pain During IUD Insertion
NCT02020551Completed
- Sponsor
- Kayseri Education and Research Hospital
- Start
- May 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in pain (2 arms), sponsored by Kayseri Education and Research Hospital. Primary endpoint: Pain at 3 months. Started May 2013; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT02020551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020551.